Egetis Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	142.5	215.8	351	303.3	127.7	144
Cash & Short-Term Investments	142.5	215.8	351	303.3	127.7	144
Cash Growth	-47.76%	-38.52%	15.73%	137.51%	-11.32%	-49.97%
Accounts Receivable	5.2	19.2	15.5	28.2	3.8	3.5
Other Receivables	7.1	8.7	8.1	8.2	6.4	3.3
Total Trade Receivables	12.3	27.9	23.6	36.4	10.2	6.8
Inventory	1.8	2.3	1	0.7	0.6	0.7
Other Current Assets	6.6	7.5	4.5	5.5	8.9	1.4
Total Current Assets	163.2	253.6	380.1	345.9	147.4	152.9
Net Property, Plant & Equipment	9	9.7	2.6	4.4	2.7	4.3
Other Intangible Assets	362.9	373.3	408	409.1	410.2	411.3
Long-Term Investments	0.8	0.8	0.8	0.8	0.8	0.8
Other Long-Term Assets	1.6	1.7	0.6	-	-	-
Total Assets	537.4	639.1	792.3	760.2	561.1	569.3
Accounts Payable	23.1	21.8	25.7	28.7	20	4.6
Accrued Expenses	170.3	176.7	137.2	63	23.7	17.4
Current Portion of Long-Term Debt	32.4	31.5	30.1	5.2	-	-
Other Current Liabilities	10.9	10.9	11.2	6.9	5.7	17.2
Total Current Liabilities	236.8	240.9	204.2	103.9	49.4	39.2
Long-Term Debt	37.9	45	84.1	103.4	-	-
Other Long-Term Liabilities	14	14.5	11.1	7.3	5.5	3.1
Total Long-Term Liabilities	51.9	59.5	95.2	110.8	5.5	3.1
Total Liabilities	288.7	300.4	299.4	214.7	54.9	42.3
Common Stock	22.3	22.3	20.4	15.4	11.3	8.7
Additional Paid-in Capital	2,228	2,228	2,058	1,780	1,428	1,263
Accumulated Other Comprehensive Income	41.4	36.8	24.8	16.7	6.1	1.3
Retained Earnings	-2,043	-1,948	-1,610	-1,267	-939.6	-745.8
Shareholders' Equity	248.6	338.7	492.9	545.6	506.2	527
Total Liabilities & Equity	537.4	639.1	792.3	760.2	561.1	569.3
Total Debt	70.3	76.5	114.2	108.6	0	0
Net Cash (Debt)	72.2	139.3	236.8	194.7	127.7	144
Net Cash Growth	-48.17%	-41.17%	21.62%	52.47%	-11.32%	-49.97%
Net Cash Per Share	0.19	0.37	0.76	0.75	0.66	0.80
Book Value	248.6	338.7	492.9	545.6	506.2	527
Book Value Per Share	0.65	0.91	1.59	2.10	2.61	2.93
Tangible Book Value	-114.3	-34.6	84.9	136.5	96	115.7
Tangible Book Value Per Share	-0.30	-0.09	0.27	0.52	0.49	0.64